We retrospectively reviewed 56 adults with culturenon-HIV-infected (76.9% vs. 9.1%; p=0.0001) and 23.1% had 'breakthrough' TBM. CSF analysis proven tuberculous meningitis (TBM), investigating clinical signs, cerebrospinal fluid (CSF) findings and revealed 12 patients (21.4%) with acellular fluid (more common in those Á60 years of age, p= outcome. There were 50 patients, aged 18-59 years, 39 with and 11 without human immunodeficiency 0.016), of whom three had completely normal CSF. A neutrophil predominance was found in 22 patients virus (HIV) infection. Six were aged 60 years or older. Neurological signs of TBM in 18-59-year-olds (39.3%). Only three patients (5.4%) had a positive CSF smear for acid-fast bacilli. In-hospital mortality were unaffected by HIV serostatus while, compared to those Á60 years of age, there were more patients occurred in 39 patients (69.1%), was similar in all study groups, and was not related to neurological with meningism (86.0% vs. 33.3%; p=0.011) and fewer with seizures (12.0% vs. 50.0%; p=0.046).
Introduction
Tuberculous meningitis (TBM), which continues to and outcome of TBM in adults at Chris Hani Baragwanath Hospital, Soweto, South Africa. cause high morbidity and mortality rates, has acquired added significance in the era of human immunodeficiency virus (HIV) infection, with studies in Spain1 and the Ivory Coast2 showing a markedly Methods increased risk for TBM in HIV-infected patients with tuberculosis. Most reports on TBM in adults in the Chris Hani Baragwanath Hospital is a 3300-bed public university hospital serving an estimated popu1990s have focused on developed countries.1,3-8 These patient populations may not reflect TBM as lation of 3 million people. The patient population included adults who had Mycobacterium tubercuseen in developing countries.
In South Africa, tuberculosis is endemic, with losis cultured in cerebrospinal fluid (CSF) between March 1994 and March 1997. Patients were estimated case rates exceeding 400/100 000 population,9 while there were an estimated 1.8 million excluded if they had abnormal CSF findings due to a bloody tap, if they were <60 years of age and adults infected with HIV by 1996.10 In Soweto, South Africa, TBM is the commonest cause of adult were not tested for HIV antibodies, or if there was an alternative cause for their neurological presentameningitis.11
This study was performed in order to describe the tion with the only evidence for tuberculosis being a culture from a single specimen of CSF. clinical presentation, cerebrospinal fluid findings, The remaining patients were divided into three on antituberculous therapy for durations ranging from 3 days to 5 months before symptoms or signs of groups: HIV-seropositives aged 18-59 years, HIVseronegatives aged 18-59 years, and patients older tuberculous meningitis became apparent and lumbar puncture was performed. This situation has been than 59 years. Their case records were reviewed using a protocol to identify demographic charactercalled 'breakthrough' TBM. Three of these nine were referred from TB sanatoria, while no data were istics, laboratory and radiological data, and outcome. Table 2 ). The three patients who and examined by fluorescent microscopy using an auramine stain for acid-fast bacilli. Concentrated had an entirely normal CSF analysis all had evidence of extrameningeal tuberculosis-two had pulmonary specimens were inoculated on to both a LowensteinJensen medium and into a Bactec 12B vial tuberculosis and one had miliary tuberculosis. A normal protein level was found in eight patients (Middlebrook 7H12 agar) for culture. Susceptibility testing was performed using the Bactec system.
(14.3%) and a normal glucose level in 12 (21.4%). Only 15 patients (26.8%) had typical CSF findings The x2 or Fisher's exact tests were used in the analysis. Values of p<0.05 were considered statisticof tuberculous meningitis (lymphocyte predominance with raised protein and a low glucose level), while ally significant. 22 (39.3%) had a neutrophil predominance. A positive smear for acid-fast bacilli was found in three patients (5,4%). Of the 47 patients for whom drug
Results
susceptibilities were available, five (10.6%) had organisms resistant to either isoniazid or rifampicin Eighty-five patients were originally identified, of whom 10 had missing bedletters, seven were aged and two (4.3%) had tuberculosis resistant to both drugs (multidrug resistance). Two of these patients 18-59 years and had unknown HIV serostatus, seven had another cause for their neurological presentation had 'breakthrough' TBM. CT brain scans were performed on 15 patients; only two were initially and five had a bloody tap. Fifty-six patients met the selection criteria and were analysed, including 39 normal. Abnormalities found included five scans with cerebral infarction, three with hydrocephalus, HIV-infected and 11 non-HIV-infected individuals aged 18-59 years and six patients aged 60 years and one each with basal meningeal enhancement, cerebritis, tuberculoma, cerebral atrophy and white and older. None of this last group had clinical findings suggestive of HIV infection; the only person matter degeneration. Death, while hospitalized for diagnosis and initial tested was HIV-seronegative.
All the subjects had abnormal neurological symptreatment of tuberculous meningitis, occurred in 39 patients (69.6%) ( Table 3 ). There was no significant toms or signs before tuberculous meningitis was diagnosed. Initial symptoms and duration of illness difference in outcome by neurological stage or age group. Ten patients (17.9%) received no therapy, of were available in too few patients for analysis to be performed. Clinical signs at presentation were similar whom seven died and three were discharged prior to the diagnosis being considered. There was a in 18-59-year-olds irrespective of HIV serostatus except for a significant increase in HIV-seropositives significant difference in mortality between those who started antituberculosis treatment within 24 h of with clinical or radiological findings suggestive of extrameningeal, predominantly pulmonary, tubercuadmission (14/25 died, 56.0%) and those in whom therapy was delayed for at least 24 h, (19/21 died, losis ( p=0.0001) ( Table 1) .
In those Á60 years of age compared to 90.5%) ( p=0.024). Seven of those with delayed treatment had lumbar punctures postponed until after 18-59-year-olds, there was significantly less meningism ( p=0.011) and more frequent seizures ( p= CT brain scans were performed, for which they had to wait at least 24 h. Only six patients received 0.046). Nine (23.1%) of the HIV-infected had been corticosteroids, all of whom died. All three patients frequent meningism in those with acellular fluid ( p=0.045) (data not shown). with normal CSF died, as did seven of the nine on antituberculous therapy prior to admission and six of the seven with resistant organisms. Death occurred in 7/9 (77.8%) patients with CD4<100/mm3, 3/5 Discussion (60%) with CD4 100-200/mm3 and 6/7 (85.7%) with CD4>200/mm3 ( p=NS).
The clinical and laboratory manifestations and outcome of TBM among AIDS patients did not differ Comparison of clinical presentation and outcome between those with acellular fluid and those with a significantly from those of non-HIV-infected subjects, confirming the findings of other series.1,7,8 Diagnosis white blood cell pleocytosis in CSF revealed no significant differences other than significantly less of TBM was facilitated by the frequent occurrence of tuberculosis outside the central nervous system, second lumbar punctures to assess whether pleocytosis had developed. Early-stage patients and those which was significantly more common among the HIV-infected. Extrameningeal tuberculosis has been who present acutely may have a neutrophil predominance and near-normal chemistry in the initial found in 41-68% of patients in other studies,1,4-7 which is lower than the 76.9% of HIV-infected lumbar puncture; such neutrophil predominance has been seen in 22-32% of patients in other studin our study, but similar to the 60.7% overall. 'Breakthrough' TBM, which has been described1, 6, 7, 14 ies.1,3,4,6,11,14,15 A low yield on direct smear of CSF, i.e. less than 15%, is not uncommon3,4,6,14 although would seem to be predominantly, though not exclusively, related to poor compliance7 or drug-resistant it can be increased to 87% with large volumes of CSF and repeated lumbar punctures.15 tuberculosis.
The two major problems identified in this study Mortality rates of TBM in published studies range from 3-70% with most recent series reporting morwere the presence of obstacles to a timely diagnosis of TBM and the extremely high mortality. The tality below 35%.1,3,5,8,14,15 The high death rates occurred in series where medical care was instituted difficulty in establishing the diagnosis of TBM is well recognized.13 The absence of meningism, which is late in the course of the disease18 or where patients were mostly in neurological stage 3.6 In our study, more common in the elderly,14 requires a high index of clinical suspicion. In resource-poor countries, the duration of illness was not available, and mortality was not significantly related to stage of illness, patients with focal signs or elderly patients with seizures may have significant delays before lumbar possible due to the small numbers of patients. Corticosteroids were used in only six patients, none puncture while awaiting a CT brain scan. Atypical CSF findings may add to the difficulties of diagnosis of whom survived. The fact of culture positivity in CSF may itself have been a major poor prognostic in the form of neutrophil predominance, acellular or even normal CSF, especially if there is a low yield factor.19 Delays in therapy of >24 h resulted in a higher mortality, leaving little margin for error in of direct smear for acid-fast bacilli. Acellular CSF in TBM has been noted in both HIV-seropositive and diagnosis.
The results of this study may not be applicable to non-HIV infected patients,1,4,7,8,11,14,15 while a completely normal CSF has been found in HIV-seroposiall adults with TBM in our setting due both to the small numbers of both patients aged 60 years and tives.1,7 In a subanalysis of a Spanish study, 4/25 AIDS patients at one hospital had acellular CSF, older, and non-HIV-infected 18-59-year-olds, as well as the strict inclusion criteria used. Mortality was none of whom experienced headaches and only one of whom had meningeal signs.16 Although all patients 40% in a previous study of TBM at this hospital in which a broader definition of TBM was used, with in this study had neurological symptoms or signs, meningism was significantly less common in the only 21% of patients having CSF cultures which were positive.11 patients with acellular CSF, a combination which may delay diagnosis in the absence of extramenin-A great need exists for a rapid, sensitive, cheap and easily applied test for TBM. Until such a test geal tuberculosis. Fortunately, all but three of the patients with acellular CSF had abnormal chemistry becomes available, a high index of suspicion for TBM, coupled to the testing of large volumes of CSF and the three subjects with normal CSF all had evidence of tuberculosis outside the central nervous repeatedly in suspicious cases, remains the only route to a more rapid diagnosis. system. None of the patients with acellular CSF had
